Prudo-Chlebosz Raymond bought AKTX
August 18, 2026 · Form 4 insider transaction
Prudo-Chlebosz Raymond bought 9,072 shares of Akari Therapeutics, Plc at $7.90 per share, a transaction worth $71.7K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 59 days after the transaction.
Footnotes
These American Depositary Shares ("ADSs") represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. This RSU grant was approved by the Board of Directors of the Issuer on August 18, 2026, and is subject to forfeiture if shareholder approval of a proposed amendment to the Issuer's equity incentive plan to increase the number of shares reserved for issuance under the plan ("Shareholder Approval") is not obtained. The RSUs will vest in full on the date of Shareholder Approval.; This award of RSUs was granted in lieu of accrued but unpaid cash retainers payable to non-execute directors in accordance with the Issuer's remuneration policy.